Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.40 |
| ▸ | MAPT | P10636 | 3/20 | 0.40 |
| ▸ | NPC1 | O15118 | 2/20 | 0.40 |
| ▸ | RAB9A | P51151 | 2/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.40 |
| ▸ | HPGD | P15428 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | CASP1 | P29466 | 1/20 | 0.40 |
| ▸ | HBB | P68871 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | JUN | P05412 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14867 | 0.92 | — | — | |
| SCHEMBL28222778 | 0.92 | ALDH1A1 (0.59) | ALDH1A1TSHRHDAC8SMN1; SMN2MAPT | |
| Methyl Alcohol SCHEMBL28761443 | 0.90 | ALDH1A1 (0.50) | ALDH1A1TSHRHDAC8SMN1; SMN2MAPT | |
| Propene SCHEMBL28134985 | 0.90 | ALDH1A1 (0.50) | ALDH1A1TSHRHDAC8SMN1; SMN2MAPT | |
| Hydrochloric Acid SCHEMBL220696 | 0.89 | — | — | |
| SCHEMBL9405395 | 0.89 | — | — | |
| SCHEMBL9693194 | 0.89 | — | — | |
| Bromide SCHEMBL3107187 | 0.89 | ALDH1A1 (0.56) | ALDH1A1TSHRHDAC8SMN1; SMN2MAPT | |
| SCHEMBL1462870 | 0.89 | — | — | |
| SCHEMBL8609621 | 0.89 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6712949-B2 | EMPLOYING REDOX CATALYSTS IN GAS DIFFUSION ELECTRODE OR MEMBRANE ELECTRODE ASSEMBLY IN SEMI-CHEMICAL/ELECTROCHEMICAL SYSTEM FOR PRODUCTION OF HIGH PURITY, STABLE AQUEOUS SOLUTIONS OF PEROXIDE AT HIGH EFFICIENCIES | THE ELECTROSYNTHESIS COMPANY, INC. | 2004-03-30 | — | — | US | claimed |
| WO-2003010360-A1 | ELECTROCHEMICAL SYNTHESIS OF HYDROGEN PEROXIDE | THE ELECTROSYNTHESIS COMPANY, INC. (US) | 2003-02-06 | — | — | WO | claimed |
| CN-115326901-B | Nanopore sequencer | 伊鲁米纳公司 | 2024-03-01 | — | — | CN | disclosed |
| CN-115326901-A | Nanopore sequencer | 伊鲁米纳公司 | 2022-11-11 | — | — | CN | disclosed |
| CN-111247428-B | Nanopore sequencer | 伊鲁米纳公司 | 2022-08-23 | — | — | CN | disclosed |
| CN-111247428-A | Nanopore sequencer | 伊鲁米纳公司 | 2020-06-05 | — | — | CN | disclosed |
| US-7456322-B2 | Process for preparing 1,3-dibromoacetone, 1-3-dichloroacetone and epichlorohydrin | DOW GLOBAL TECHNOLOGIES INC. (US) | 2008-11-25 | — | — | US | disclosed |
| US-20080249324-A1 | Process For Preparing 1,3-Dibromoacetone, 1-3-Dichloroacetone and Epichlorohydrin | DAVIS CLARK S | 2008-10-09 | — | — | US | disclosed |
| US-7388019-B2 | 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes | MERCK & CO., INC. (US) | 2008-06-17 | — | — | US | disclosed |
| EP-1758843-A2 | PROCESS FOR PREPARIING 1,3-DIBROMOACETONE, 1-3-DICHLOROACETONE AND EPICHLOROHYDRIN | Dow Gloval Technologies Inc. (US) | 2007-03-07 | — | — | EP | disclosed |
| US-20060074087-A1 | 3-Amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes | MERCK SHARP & DOHME LLC | 2006-04-06 | — | — | US | disclosed |
| WO-2005115954-A2 | PROCESS FOR PREPARIING 1,3-DIBROMOACETONE, 1-3-DICHLOROACETONE AND EPICHLOROHYDRIN | DOW GLOBAL TECHNOLOGIES INC. (US) | 2005-12-08 | — | — | WO | disclosed |
| US-6712949-B2 | EMPLOYING REDOX CATALYSTS IN GAS DIFFUSION ELECTRODE OR MEMBRANE ELECTRODE ASSEMBLY IN SEMI-CHEMICAL/ELECTROCHEMICAL SYSTEM FOR PRODUCTION OF HIGH PURITY, STABLE AQUEOUS SOLUTIONS OF PEROXIDE AT HIGH EFFICIENCIES | THE ELECTROSYNTHESIS COMPANY, INC. | 2004-03-30 | — | — | US | disclosed |
| US-20030019758-A1 | Electrochemical synthesis of hydrogen peroxide | THE ELECTROSYNTHESIS COMPANY, INC. | 2003-01-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060074087-A1 | 3-Amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes | DPP4, DPP3, DPP7 | ALDH1A1 686/4885TSHR 4488/4885HDAC8 2888/4885 |
| US-20080249324-A1 | Process For Preparing 1,3-Dibromoacetone, 1-3-Dichloroacetone and Epichlorohydrin | DBN1, GNPAT, HKDC1 | ALDH1A1 692/4885TSHR 4178/4885HDAC8 2347/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.